Baxalta Company Profile (NASDAQ:BXLT)

About Baxalta

Baxalta logoBaxalta Incorporated (Baxalta) is a biopharmaceutical company with a portfolio of differentiated therapies that seek to address medical needs across various disease areas, including hemophilia, immunology and oncology. Baxalta's categories of products include Hemophilia products, such as Advate, Adynovate, Recombinate, Hemofil M, Immunate, Immunine, Rixubis and Prothromplex Total; Inhibitor Therapies products, including FEIBA and OBIZUR; Immunoglobulin Therapies products, which include GAMMAGARD LIQUID/KIOVIG, HYQVIA, GAMMAGARD S/D and SUBCUVIA; BioTherapeutics products, including FLEXBUMIN, BUMINATE, ARALAST NP, GLASSIA NP and CEPROTIN, and Oncology product, such as ONCASPAR. Baxalta Company develops, manufactures and markets a portfolio of treatments for hemophilia and other bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute medical conditions, as well as oncology treatments for acute lymphoblastic leukemia.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BXLT
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $
  • 200 Day Moving Average: $
  • 52-Week Range: $32.40 - $46.52
  • Trailing P/E Ratio:
  • Foreward P/E Ratio: 18.12
  • P/E Growth:
  • Market Cap: $
Additional Links:

Analyst Ratings

Consensus Ratings for Baxalta (NASDAQ:BXLT) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Baxalta (NASDAQ:BXLT)
No equities research coverage for this company has been tracked by


Earnings History for Baxalta (NASDAQ:BXLT)
No earnings announcements for this company have been tracked by


Earnings Estimates for Baxalta (NASDAQ:BXLT)
Current Year EPS Consensus Estimate: $2.19 EPS
Next Year EPS Consensus Estimate: $2.54 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.46$0.46$0.46
Q2 20161$0.53$0.53$0.53
Q3 20161$0.56$0.56$0.56
Q4 20161$0.62$0.62$0.62
Q1 20171$0.53$0.53$0.53
Q2 20171$0.58$0.58$0.58
Q3 20171$0.61$0.61$0.61
Q4 20171$0.69$0.69$0.69
(Data provided by Zacks Investment Research)


Dividend History for Baxalta (NASDAQ:BXLT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Baxalta (NASDAQ:BXLT)
No insider trades for this company have been tracked by


Latest Headlines for Baxalta (NASDAQ:BXLT)
News IconHealthcare News Buzz: Valeant Pharmaceuticals Intl Inc(NYSE:VRX), Baxalta Inc (NYSE:BXLT) - NYSE Journal (press release) (NASDAQ:BXLT) - May 24 at 3:02 PM logoBaxalta Inc (NYSE:BXLT) & CVS Health Corp (NYSE:CVS) Healthcare Stock's Buzzers - Wall Street 24 (NASDAQ:BXLT) - May 24 at 3:02 PM logoBAXALTA INC Financials (NASDAQ:BXLT) - May 14 at 1:04 PM logoShort Sellers Dump Amgen And Baxalta - Benzinga (NASDAQ:BXLT) - May 13 at 2:41 PM logoShort Sellers Dump Amgen And Baxalta (NASDAQ:BXLT) - May 13 at 8:56 AM logoBRIEF-Baxalta Inc sets quarterly cash dividend of $0.07 per share (NASDAQ:BXLT) - May 10 at 6:00 PM logoAs Shire-Baxalta merger nears, lots of unanswered questions remain (NASDAQ:BXLT) - May 9 at 2:05 PM
News IconStock's Earnings Analysis: Baxalta Inc (NYSE:BXLT) - News Oracle (NASDAQ:BXLT) - May 4 at 2:26 PM logoBiotech Stock to Lookout: Baxalta Inc (NYSE:BXLT), Gilead Sciences, Inc. (NASDAQ:GILD), Medivation Inc (NASDAQ ... - The Point Review (NASDAQ:BXLT) - May 4 at 2:26 PM
News IconHC Stocks Highlights: Medivation Inc (MDVN), Teva Pharmaceutical Industries Ltd (TEVA), Baxalta Inc (BXLT) - share market updates (press release) (NASDAQ:BXLT) - May 3 at 2:39 PM logoAllergan plc Ordinary Shares (NYSE:AGN) & Baxalta Inc (NYSE:BXLT) Stocks Alert - Wall Street 24 (NASDAQ:BXLT) - May 3 at 2:39 PM logoTwo Biotech stocks to Watch: Baxalta Incorporated (NYSE:BXLT) , ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) - Is stories (NASDAQ:BXLT) - May 3 at 2:39 PM logoBiogen Spinning Off Hemophilia Business As Competition Heats Up (NASDAQ:BXLT) - May 3 at 10:27 AM logoBaxalta, Inc. :BXLT-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:BXLT) - May 3 at 10:01 AM
News IconCurrent Trade Roundup: Baxalta Inc (BXLT), NXP Semiconductors NV (NXPI) - News Oracle (NASDAQ:BXLT) - April 29 at 2:43 PM logoEarnings Recap: Baxalta Inc (NYSE:BXLT) - The Point Review (NASDAQ:BXLT) - April 29 at 2:43 PM logoShire jumps as Vyvanse drug helps it to beat earnings forecast (NASDAQ:BXLT) - April 29 at 8:48 AM logo[$$] Shire Posts First-Quarter Profit, Revenue Growth (NASDAQ:BXLT) - April 29 at 8:47 AM logoBaxalta (BXLT) Beats on Q1 Earnings, Set to Merge with Shire (NASDAQ:BXLT) - April 28 at 11:41 AM logoBaxalta (BXLT) Beats on Q1 Earnings, Revenues Rise Y/Y (NASDAQ:BXLT) - April 28 at 10:48 AM logo[$$] Shire Shareholders Rebel Over CEO Pay (NASDAQ:BXLT) - April 28 at 9:38 AM logoThe Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, Novartis, Baxalta Incorporated and Shire (NASDAQ:BXLT) - April 28 at 9:30 AM logoBaxalta posts 1Q profit (NASDAQ:BXLT) - April 28 at 8:37 AM logoShort Sellers Dump Vertex, Load Up On Baxalta (NASDAQ:BXLT) - April 28 at 8:34 AM
News IconHC Stocks Vigilant: Baxalta Inc (BXLT), Ionis Pharmaceuticals Inc (IONS), Quintiles Transnational Holdings Inc (Q) - share market updates (press release) (NASDAQ:BXLT) - April 20 at 2:50 PM logoWhy BioMarin is Soaring (NASDAQ:BXLT) - April 20 at 10:07 AM logoAnalysts Observing Recap: Skyline Medical Inc. (NASDAQ:SKLN) , Baxalta Incorporated (_ - Street Updates (NASDAQ:BXLT) - April 19 at 2:51 PM
News IconCheck on Stock Rating Baxalta Inc (NYSE:BXLT) - Business Standard Tribune (NASDAQ:BXLT) - April 18 at 2:58 PM logoCVS Health (NYSE:CVS) & Baxalta Inc (NYSE:BXLT) Stocks in the News - Wall Street 24 (NASDAQ:BXLT) - April 16 at 2:10 PM
News IconBaxalta Inc (NYSE:BXLT) Ratios & Valuation in Focus - Orygun Business News (NASDAQ:BXLT) - April 16 at 2:10 PM
News IconLvm Capital Management Ltdmi Lowers stake in Baxalta Inc (BXLT) - Market Digest (NASDAQ:BXLT) - April 16 at 2:10 PM logoTwo Movers inside Analysts Radar: Baxalta Incorporated (NYSE:BXLT) , Aetna Inc. (NYSE:AET) - Street Updates (NASDAQ:BXLT) - April 16 at 2:10 PM
News IconEarnings Watch on Baxalta Inc (NYSE:BXLT) - (NASDAQ:BXLT) - April 16 at 2:10 PM
News IconHC Stocks Overview: AbbVie Inc (ABBV), Hologic Inc. (HOLX), Baxalta Inc (BXLT) - share market updates (press release) (NASDAQ:BXLT) - April 14 at 2:50 PM
News IconShares in Focus - Baxalta Inc (NYSE:BXLT) - Stock Caller (NASDAQ:BXLT) - April 13 at 3:03 PM logoBaxalta Inc (NYSE:BXLT) Analyst Recommendation Outlook - Clinton Financial (NASDAQ:BXLT) - April 12 at 2:42 PM
News Icon2 Best Healthcare sector Stocks: Exelixis (EXEL), Baxalta Inc (BXLT) - News Oracle (NASDAQ:BXLT) - April 11 at 2:58 PM
News IconView on Ratings Baxalta Inc (NYSE:BXLT) - Business Standard Tribune (NASDAQ:BXLT) - April 11 at 2:58 PM
News IconU.S. Stocks Alert: Sprint Corp (S), Baxalta Inc (BXLT) - News Oracle (NASDAQ:BXLT) - April 8 at 2:46 PM
News IconHC Stocks Analysis: Baxalta (BXLT), Gilead Sciences (GILD), Endo International plc (ENDP) - share market updates (press release) (NASDAQ:BXLT) - April 8 at 2:46 PM
News IconAltrinsic Global Advisors buys $99.6 Million stake in Baxalta Inc (BXLT) - Street Edition (NASDAQ:BXLT) - April 8 at 2:46 PM
News IconEarnings View for Baxalta Inc (NYSE:BXLT) - (NASDAQ:BXLT) - April 8 at 2:46 PM logoCongress Must Amend the Federal Reserve Act Before the Next Recession (NASDAQ:BXLT) - April 8 at 8:01 AM
News IconBaxalta Inc. (NYSE:BXLT) announced that the Ministry of Health, Labour and Welfare in Japan approved ADYNOVATE ... - Inside Trade (NASDAQ:BXLT) - April 6 at 2:35 PM
News IconBaxalta Inc (NYSE:BXLT)'s Adynovate Receives Approval of Japanese Health Ministry - Journal Transcript (NASDAQ:BXLT) - April 6 at 2:35 PM
News IconFusion Investment Group Exits Position in Baxalta Inc (BXLT) - Everything HUDSON (NASDAQ:BXLT) - April 6 at 2:35 PM logoBill Ackman Hints Who Valeant’s Next CEO Will Be (NASDAQ:BXLT) - April 6 at 2:12 PM logoTake Advantage of Biotech's Bear Market Bounce (IBB, CELG) (NASDAQ:BXLT) - April 6 at 12:55 PM logoBaxalta, Inc. breached its 50 day moving average in a Bearish Manner : BXLT-US : April 6, 2016 (NASDAQ:BXLT) - April 6 at 8:10 AM logoBiotech Mid-day Movers: Baxalta Inc (NYSE:BXLT), Cytori Therapeutics Inc (NASDAQ:CYTX), Geron Corporation ... - The Point Review (NASDAQ:BXLT) - April 5 at 2:03 PM


Baxalta (NASDAQ:BXLT) Chart for Thursday, October, 27, 2016

Last Updated on 10/27/2016 by Staff